Literature DB >> 25716177

Ibrutinib is an effective treatment of autoimmune haemolytic anaemia in chronic lymphocytic leukaemia.

Sudhir Manda1, Nancy Dunbar1, Cynthia R Marx-Wood1, Alexey V Danilov2,3.   

Abstract

Entities:  

Keywords:  autoimmune haemolytic anaemia; chronic lymphocytic leukaemia; ibrutinib

Mesh:

Substances:

Year:  2015        PMID: 25716177     DOI: 10.1111/bjh.13328

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  15 in total

1.  Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre.

Authors:  Paul J Hampel; Melissa C Larson; Brian Kabat; Timothy G Call; Wei Ding; Saad S Kenderian; Deborah Bowen; Justin Boysen; Susan M Schwager; Jose F Leis; Asher A Chanan-Khan; Eli Muchtar; Curtis A Hanson; Susan L Slager; Neil E Kay; Kari G Chaffee; Tait D Shanafelt; Sameer A Parikh
Journal:  Br J Haematol       Date:  2018-08-16       Impact factor: 6.998

Review 2.  Targeting B Cell Signaling in Chronic Lymphocytic Leukemia.

Authors:  Jon E Arnason; Jennifer R Brown
Journal:  Curr Oncol Rep       Date:  2017-09       Impact factor: 5.075

3.  Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib.

Authors:  Candida Vitale; Inhye E Ahn; Mariela Sivina; Alessandra Ferrajoli; William G Wierda; Zeev Estrov; Sergej N Konoplev; Nitin Jain; Susan O'Brien; Mohammed Farooqui; Michael J Keating; Adrian Wiestner; Jan A Burger
Journal:  Haematologica       Date:  2016-03-24       Impact factor: 9.941

4.  Is there a role for anti-CD20 antibodies in CLL?

Authors:  Harsh R Shah; Deborah M Stephens
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

5.  Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program.

Authors:  Georg Gelbenegger; Christian Schoergenhofer; Ulla Derhaschnig; Nina Buchtele; Christian Sillaber; Michael Fillitz; Thomas M Schenk; Shirley D'Sa; Ronwyn Cartwright; James C Gilbert; Bernd Jilma; Ulrich Jaeger
Journal:  Blood Adv       Date:  2020-03-24

6.  Ibrutinib Is Effective in the Treatment of Autoimmune Haemolytic Anaemia in Mantle Cell Lymphoma.

Authors:  Aliénor Galinier; Vincent Delwail; Mathieu Puyade
Journal:  Case Rep Oncol       Date:  2017-01-27

7.  Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study.

Authors:  M Montillo; S O'Brien; A Tedeschi; J C Byrd; C Dearden; D Gill; J R Brown; J C Barrientos; S P Mulligan; R R Furman; F Cymbalista; C Plascencia; S Chang; E Hsu; D F James; P Hillmen
Journal:  Blood Cancer J       Date:  2017-02-03       Impact factor: 11.037

8.  Chronic Lymphocytic Leukemia Presenting as a Subcortical Watershed Infarct.

Authors:  Mridul Gupta; Divita Singh; Patrick Lee; Sandhya Kadiyam
Journal:  Case Rep Hematol       Date:  2019-01-09

9.  Cryoglobulinemic vasculitis with interruption of ibrutinib therapy for chronic lymphocytic leukemia (CLL).

Authors:  Nicholas Wright; Ensi Voshtina; Gemlyn George; Arun Singavi; Joshua Field
Journal:  Int J Hematol       Date:  2019-09-07       Impact factor: 2.319

10.  [Ibrutinib treatment for 2 cases of relapsed/refractory autoimmune hemolytic anemia: a pilot study].

Authors:  L W Fang; H Pan; J Shi
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.